These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12102155)

  • 1. Growth factor-induced cell motility in tumor invasion.
    Wells A; Kassis J; Solava J; Turner T; Lauffenburger DA
    Acta Oncol; 2002; 41(2):124-30. PubMed ID: 12102155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility is rate-limiting for invasion of bladder carcinoma cell lines.
    Kassis J; Radinsky R; Wells A
    Int J Biochem Cell Biol; 2002 Jul; 34(7):762-75. PubMed ID: 11950593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor invasion: role of growth factor-induced cell motility.
    Wells A
    Adv Cancer Res; 2000; 78():31-101. PubMed ID: 10547668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.
    Turner T; Chen P; Goodly LJ; Wells A
    Clin Exp Metastasis; 1996 Sep; 14(4):409-18. PubMed ID: 8878415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
    Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP].
    Fang WG; Tian XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 49(2):188-195. PubMed ID: 28416823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor invasion as dysregulated cell motility.
    Kassis J; Lauffenburger DA; Turner T; Wells A
    Semin Cancer Biol; 2001 Apr; 11(2):105-17. PubMed ID: 11322830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain-2 as a target for limiting prostate cancer invasion.
    Mamoune A; Luo JH; Lauffenburger DA; Wells A
    Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.
    Grahovac J; Wells A
    Lab Invest; 2014 Jan; 94(1):31-40. PubMed ID: 24247562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
    Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas (Review).
    Hagedorn HG; Bachmeier BE; Nerlich AG
    Int J Oncol; 2001 Apr; 18(4):669-81. PubMed ID: 11251160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling.
    Eccles SA
    Recent Results Cancer Res; 2000; 157():41-54. PubMed ID: 10857161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression.
    Theodorescu D; Laderoute KR; Calaoagan JM; Guilding KM
    Int J Cancer; 1998 Dec; 78(6):775-82. PubMed ID: 9833772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor stimulation can substitute for c-Src overexpression in promoting breast carcinoma invasion.
    Lotz M; Wang HH; Cance W; Matthews J; Pories S
    J Surg Res; 2003 Feb; 109(2):123-9. PubMed ID: 12643853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype.
    Leach RE; Kilburn B; Wang J; Liu Z; Romero R; Armant DR
    Dev Biol; 2004 Feb; 266(2):223-37. PubMed ID: 14738873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
    Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells.
    Hamada J; Nagayasu H; Takayama M; Kawano T; Hosokawa M; Takeichi N
    Cancer Lett; 1995 Mar; 89(2):161-7. PubMed ID: 7889524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.